COVID-19 vaccination status and disease burden in patients with sickle cell disease

Br J Haematol. 2022 Nov;199(4):e21-e24. doi: 10.1111/bjh.18443. Epub 2022 Sep 4.

Authors

Jin Han^{1

2}, Xu Zhang², Robert E Molokie^{2

3}, Franklin U Njoku², Faiz A Hussain², Marwah Farooqui², Insia Rizvi², Santosh L Saraf², Victor R Gordeuk²

Affiliations

¹ Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.
² Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
³ Department of Medicine, Jesse Brown VA Medical Center, Chicago, Illinois, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / epidemiology
COVID-19 Vaccines
COVID-19* / prevention & control
Cost of Illness
Humans
Vaccination

Substances

COVID-19 Vaccines

Grants and funding